187 related articles for article (PubMed ID: 29303514)
1. Depletion of S100A4
Jiao J; González Á; Stevenson HL; Gagea M; Sugimoto H; Kalluri R; Beretta L
Exp Mol Med; 2018 Jan; 50(1):e422. PubMed ID: 29303514
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of cancer-initiating cells stemness properties by abrogating S100A4 calcium binding ability in head and neck cancers.
Cheng LH; Hung KF; Huang TF; Hsieh HP; Wang SY; Huang CY; Lo JF
Oncotarget; 2016 Nov; 7(48):78946-78957. PubMed ID: 27793047
[TBL] [Abstract][Full Text] [Related]
3. Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3.
Sun H; Wang C; Hu B; Gao X; Zou T; Luo Q; Chen M; Fu Y; Sheng Y; Zhang K; Zheng Y; Ren X; Yan S; Geng Y; Yang L; Dong Q; Qin L
Signal Transduct Target Ther; 2021 May; 6(1):187. PubMed ID: 34035222
[TBL] [Abstract][Full Text] [Related]
4. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
[TBL] [Abstract][Full Text] [Related]
6. Proliferating EpCAM-Positive Ductal Cells in the Inflamed Liver Give Rise to Hepatocellular Carcinoma.
Matsumoto T; Takai A; Eso Y; Kinoshita K; Manabe T; Seno H; Chiba T; Marusawa H
Cancer Res; 2017 Nov; 77(22):6131-6143. PubMed ID: 28951464
[TBL] [Abstract][Full Text] [Related]
7. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
8. IL-1β promotes the nuclear translocaiton of S100A4 protein in gastric cancer cells MGC803 and the cell's stem-like properties through PI3K pathway.
Yu A; Wang Y; Bian Y; Chen L; Guo J; Shen W; Chen D; Liu S; Sun X
J Cell Biochem; 2018 Nov; 119(10):8163-8173. PubMed ID: 29932233
[TBL] [Abstract][Full Text] [Related]
9. Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice.
Miura K; Ishioka M; Minami S; Horie Y; Ohshima S; Goto T; Ohnishi H
J Biol Chem; 2016 May; 291(22):11504-17. PubMed ID: 27022031
[TBL] [Abstract][Full Text] [Related]
10. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers.
Lo JF; Yu CC; Chiou SH; Huang CY; Jan CI; Lin SC; Liu CJ; Hu WY; Yu YH
Cancer Res; 2011 Mar; 71(5):1912-23. PubMed ID: 21169409
[TBL] [Abstract][Full Text] [Related]
11. Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells.
Luo X; Liao R; Hanley KL; Zhu HH; Malo KN; Hernandez C; Wei X; Varki NM; Alderson N; Chu C; Li S; Fan J; Loomba R; Qiu SJ; Feng GS
Cell Rep; 2016 Dec; 17(11):2979-2993. PubMed ID: 27974211
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of S100A4 expression in human hepatocellular carcinoma.
Liu Z; Liu H; Pan H; Du Q; Liang J
J Int Med Res; 2013 Apr; 41(2):457-62. PubMed ID: 23781010
[TBL] [Abstract][Full Text] [Related]
13. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization.
O'Connell JT; Sugimoto H; Cooke VG; MacDonald BA; Mehta AI; LeBleu VS; Dewar R; Rocha RM; Brentani RR; Resnick MB; Neilson EG; Zeisberg M; Kalluri R
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16002-7. PubMed ID: 21911392
[TBL] [Abstract][Full Text] [Related]
14. S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma.
Chow KH; Park HJ; George J; Yamamoto K; Gallup AD; Graber JH; Chen Y; Jiang W; Steindler DA; Neilson EG; Kim BYS; Yun K
Cancer Res; 2017 Oct; 77(19):5360-5373. PubMed ID: 28807938
[TBL] [Abstract][Full Text] [Related]
15. miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells.
Zhang J; Jiao J; Cermelli S; Muir K; Jung KH; Zou R; Rashid A; Gagea M; Zabludoff S; Kalluri R; Beretta L
Cancer Res; 2015 May; 75(9):1859-67. PubMed ID: 25769721
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients.
El-Bendary M; Farid K; Arafa M; Elkashef W; Abdullah T; El-Mesery A
J Egypt Natl Canc Inst; 2023 Aug; 35(1):26. PubMed ID: 37599312
[TBL] [Abstract][Full Text] [Related]
17. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
[TBL] [Abstract][Full Text] [Related]
18.
Zhang YH; Ma Q; Ding P; Li J; Chen LL; Ao KJ; Tian YY
Yonsei Med J; 2018 Nov; 59(9):1064-1071. PubMed ID: 30328321
[TBL] [Abstract][Full Text] [Related]
19. Pten Haplodeficiency Accelerates Liver Tumor Growth in miR-122a-Null Mice via Expansion of Periportal Hepatocyte-Like Cells.
Tu WL; You LR; Tsou AP; Chen CM
Am J Pathol; 2018 Nov; 188(11):2688-2702. PubMed ID: 30165041
[TBL] [Abstract][Full Text] [Related]
20. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
